In a study of TP53 mutant non-small-cell lung cancer tumor cells, it was found that inhibiting the expression of chek1 can significantly enhance the sensitivity of tumor cells to chemotherapy [16, 17]. The gene discussed is CHEK1; the disease is non-small cell lung carcinoma.